Role of matrix metalloproteinase-9 in neurodevelopmental deficits and experience-dependent plasticity in <i>Xenopus laevis</i>.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34282726.
- Also identified by DOI 10.7554/eLife.62147 and PMC identifier 8315794.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Matrix metalloproteinase-9 (MMP-9) is a secreted endopeptidase targeting extracellular matrix proteins, creating permissive environments for neuronal development and plasticity. Developmental dysregulation of MMP-9 may also lead to neurodevelopmental disorders (ND). Here, we test the hypothesis that chronically elevated MMP-9 activity during early neurodevelopment is responsible for neural circuit hyperconnectivity observed in <i>Xenopus</i> tadpoles after early exposure to valproic acid (VPA), a known teratogen associated with ND in humans. In <i>Xenopus</i> tadpoles, VPA exposure results in excess local synaptic connectivity, disrupted social behavior and increased seizure susceptibility. We found that overexpressing MMP-9 in the brain copies effects of VPA on synaptic connectivity, and blocking MMP-9 activity pharmacologically or genetically reverses effects of VPA on physiology and behavior. We further show that during normal neurodevelopment MMP-9 levels are tightly regulated by neuronal activity and required for structural plasticity. These studies show a critical role for MMP-9 in both normal and abnormal development.
Medical subject headings
- Matrix Metalloproteinase 9
- Neurodevelopmental Disorders
- Neurogenesis
- Xenopus laevis